Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
CARD Signaling Adaptor Proteins | 8 | 2019 | 159 | 2.530 |
Why?
|
Idiopathic Pulmonary Fibrosis | 5 | 2022 | 514 | 1.420 |
Why?
|
Asthma | 22 | 2024 | 6230 | 1.390 |
Why?
|
Lung | 31 | 2023 | 9979 | 1.130 |
Why?
|
Allergens | 14 | 2023 | 1433 | 1.130 |
Why?
|
Pulmonary Fibrosis | 6 | 2024 | 505 | 1.030 |
Why?
|
Respiratory Hypersensitivity | 6 | 2019 | 271 | 0.850 |
Why?
|
Hypersensitivity | 5 | 2023 | 1167 | 0.830 |
Why?
|
Th2 Cells | 8 | 2024 | 1071 | 0.790 |
Why?
|
Capillary Permeability | 3 | 2022 | 773 | 0.770 |
Why?
|
Ovalbumin | 11 | 2015 | 671 | 0.760 |
Why?
|
Alternaria | 2 | 2018 | 42 | 0.750 |
Why?
|
Chemotaxis, Leukocyte | 8 | 2011 | 660 | 0.690 |
Why?
|
Hypertension, Pulmonary | 5 | 2012 | 1592 | 0.680 |
Why?
|
Disintegrins | 1 | 2018 | 27 | 0.640 |
Why?
|
Receptors, Leukotriene B4 | 4 | 2005 | 92 | 0.610 |
Why?
|
Orthomyxoviridae Infections | 3 | 2024 | 254 | 0.590 |
Why?
|
Chemokines, CXC | 5 | 2008 | 416 | 0.550 |
Why?
|
Eosinophils | 2 | 2011 | 951 | 0.540 |
Why?
|
Adiponectin | 6 | 2021 | 1107 | 0.530 |
Why?
|
Lysophospholipids | 3 | 2022 | 337 | 0.530 |
Why?
|
CD8-Positive T-Lymphocytes | 10 | 2021 | 4574 | 0.520 |
Why?
|
Lung Diseases | 5 | 2020 | 1910 | 0.510 |
Why?
|
Exchange Transfusion, Whole Blood | 2 | 2005 | 59 | 0.500 |
Why?
|
Airway Remodeling | 2 | 2019 | 132 | 0.480 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2022 | 2897 | 0.460 |
Why?
|
Bronchiolitis Obliterans | 2 | 2006 | 213 | 0.460 |
Why?
|
Pulmonary Eosinophilia | 3 | 2011 | 78 | 0.460 |
Why?
|
Pneumonia | 4 | 2022 | 2142 | 0.450 |
Why?
|
Pulmonary Artery | 3 | 2011 | 1929 | 0.440 |
Why?
|
CD4-Positive T-Lymphocytes | 7 | 2021 | 4372 | 0.420 |
Why?
|
Epithelial Cells | 4 | 2018 | 3671 | 0.410 |
Why?
|
Disease Models, Animal | 20 | 2024 | 18220 | 0.410 |
Why?
|
Respiratory System | 2 | 2016 | 562 | 0.410 |
Why?
|
Mice | 43 | 2024 | 81326 | 0.400 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3446 | 0.400 |
Why?
|
Receptors, Chemokine | 6 | 2008 | 654 | 0.390 |
Why?
|
Guanylate Cyclase | 1 | 2013 | 205 | 0.390 |
Why?
|
Bleomycin | 3 | 2022 | 495 | 0.370 |
Why?
|
Mice, Transgenic | 14 | 2022 | 9520 | 0.370 |
Why?
|
Respiration, Artificial | 4 | 2020 | 2631 | 0.370 |
Why?
|
Respiratory Mucosa | 3 | 2021 | 436 | 0.360 |
Why?
|
T-Lymphocytes, Regulatory | 7 | 2020 | 3092 | 0.360 |
Why?
|
Tomography, Optical Coherence | 6 | 2022 | 2923 | 0.350 |
Why?
|
T-Lymphocytes | 6 | 2013 | 10203 | 0.350 |
Why?
|
Endothelial Cells | 2 | 2022 | 3551 | 0.330 |
Why?
|
Mice, Knockout | 18 | 2018 | 14392 | 0.330 |
Why?
|
Animals | 51 | 2024 | 168079 | 0.330 |
Why?
|
Inflammation | 15 | 2023 | 10759 | 0.330 |
Why?
|
STAT6 Transcription Factor | 2 | 2009 | 196 | 0.330 |
Why?
|
Bronchial Hyperreactivity | 4 | 2010 | 301 | 0.320 |
Why?
|
Receptors, Virus | 1 | 2012 | 642 | 0.320 |
Why?
|
Mice, Inbred C57BL | 19 | 2022 | 22127 | 0.310 |
Why?
|
Receptors, CXCR3 | 7 | 2021 | 238 | 0.310 |
Why?
|
Scapula | 1 | 2010 | 173 | 0.310 |
Why?
|
Bronchoalveolar Lavage | 4 | 2016 | 129 | 0.310 |
Why?
|
Chemokine CCL20 | 1 | 2008 | 64 | 0.310 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2010 | 169 | 0.310 |
Why?
|
Chemokines | 5 | 2013 | 956 | 0.300 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 3201 | 0.290 |
Why?
|
Receptors, Purinergic P2 | 2 | 2005 | 150 | 0.290 |
Why?
|
Up-Regulation | 4 | 2012 | 4111 | 0.280 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2010 | 1488 | 0.280 |
Why?
|
Chemotaxis | 2 | 2021 | 598 | 0.280 |
Why?
|
Respiratory Mechanics | 3 | 2020 | 698 | 0.270 |
Why?
|
Anemia, Sickle Cell | 2 | 2005 | 1063 | 0.270 |
Why?
|
Bone Diseases | 1 | 2010 | 418 | 0.270 |
Why?
|
Cells, Cultured | 11 | 2018 | 18926 | 0.270 |
Why?
|
Fibroblasts | 3 | 2022 | 4137 | 0.250 |
Why?
|
Adaptive Immunity | 2 | 2024 | 724 | 0.250 |
Why?
|
Antigen-Antibody Reactions | 1 | 2005 | 340 | 0.250 |
Why?
|
Bronchoalveolar Lavage Fluid | 8 | 2021 | 753 | 0.250 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3245 | 0.240 |
Why?
|
T-Lymphocyte Subsets | 4 | 2009 | 1803 | 0.240 |
Why?
|
Bronchial Diseases | 1 | 2005 | 150 | 0.240 |
Why?
|
Smoking | 4 | 2021 | 9055 | 0.240 |
Why?
|
Lung Transplantation | 3 | 2013 | 1307 | 0.230 |
Why?
|
Interleukin-9 | 1 | 2024 | 62 | 0.230 |
Why?
|
Dendritic Cells | 1 | 2015 | 2726 | 0.230 |
Why?
|
Myeloid Cells | 1 | 2009 | 822 | 0.220 |
Why?
|
Bronchoscopy | 3 | 2021 | 909 | 0.220 |
Why?
|
Cytokines | 8 | 2016 | 7386 | 0.220 |
Why?
|
Granulocytes | 1 | 2005 | 550 | 0.220 |
Why?
|
Trachea | 2 | 2006 | 1090 | 0.210 |
Why?
|
Coronavirus Infections | 4 | 2021 | 3093 | 0.210 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2011 | 2024 | 0.210 |
Why?
|
Inflammation Mediators | 3 | 2021 | 1885 | 0.210 |
Why?
|
Ventilator Weaning | 2 | 2021 | 164 | 0.210 |
Why?
|
Pulmonary Gas Exchange | 3 | 2020 | 379 | 0.200 |
Why?
|
Respiratory Insufficiency | 2 | 2021 | 1232 | 0.200 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2008 | 1141 | 0.200 |
Why?
|
Macrophages, Alveolar | 3 | 2021 | 410 | 0.190 |
Why?
|
HIV Infections | 6 | 2021 | 17347 | 0.190 |
Why?
|
Positive-Pressure Respiration | 3 | 2020 | 638 | 0.190 |
Why?
|
Immunity, Innate | 3 | 2024 | 3044 | 0.190 |
Why?
|
Mice, Inbred BALB C | 7 | 2024 | 6199 | 0.180 |
Why?
|
Chemokine CCL24 | 2 | 2011 | 8 | 0.180 |
Why?
|
Chemokine CXCL10 | 5 | 2021 | 309 | 0.180 |
Why?
|
Lung Diseases, Obstructive | 2 | 1998 | 308 | 0.180 |
Why?
|
rho-Associated Kinases | 2 | 2023 | 281 | 0.180 |
Why?
|
Graft Rejection | 3 | 2013 | 4481 | 0.180 |
Why?
|
Viral Tropism | 1 | 2021 | 101 | 0.180 |
Why?
|
Neuroendocrine Cells | 1 | 2021 | 62 | 0.170 |
Why?
|
Acyl Coenzyme A | 1 | 2020 | 56 | 0.170 |
Why?
|
Mevalonic Acid | 1 | 2020 | 46 | 0.170 |
Why?
|
Humans | 64 | 2024 | 761208 | 0.170 |
Why?
|
HIV-1 | 3 | 2021 | 6851 | 0.170 |
Why?
|
Influenza, Human | 2 | 2021 | 1521 | 0.170 |
Why?
|
Respiratory Function Tests | 3 | 2021 | 1685 | 0.170 |
Why?
|
Sphingosine | 1 | 2022 | 307 | 0.170 |
Why?
|
Interleukins | 1 | 2024 | 782 | 0.170 |
Why?
|
Adoptive Transfer | 4 | 2011 | 823 | 0.160 |
Why?
|
Signal Transduction | 7 | 2021 | 23416 | 0.160 |
Why?
|
Receptors, Antigen, T-Cell | 4 | 2013 | 2549 | 0.160 |
Why?
|
Metalloproteases | 1 | 2018 | 61 | 0.160 |
Why?
|
International Classification of Diseases | 1 | 2024 | 915 | 0.160 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3215 | 0.150 |
Why?
|
Gene Deletion | 2 | 2022 | 2658 | 0.150 |
Why?
|
Bronchi | 3 | 2021 | 843 | 0.150 |
Why?
|
Tobacco Smoke Pollution | 1 | 2023 | 821 | 0.150 |
Why?
|
Simvastatin | 1 | 2020 | 346 | 0.140 |
Why?
|
Pulmonary Circulation | 1 | 2020 | 737 | 0.140 |
Why?
|
Interleukin-1 | 2 | 2012 | 1250 | 0.140 |
Why?
|
Pyroglyphidae | 2 | 2015 | 89 | 0.140 |
Why?
|
Lactates | 1 | 1998 | 401 | 0.140 |
Why?
|
NF-kappa B | 4 | 2015 | 2475 | 0.140 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 447 | 0.140 |
Why?
|
Immunomodulation | 1 | 2020 | 548 | 0.130 |
Why?
|
Chemokine CXCL9 | 3 | 2006 | 135 | 0.130 |
Why?
|
Exercise Tolerance | 1 | 2021 | 838 | 0.130 |
Why?
|
Muscle, Smooth | 2 | 2016 | 927 | 0.130 |
Why?
|
Obesity | 3 | 2021 | 12939 | 0.130 |
Why?
|
Blood Coagulation | 1 | 2022 | 1156 | 0.130 |
Why?
|
Cytoplasm | 1 | 2020 | 1498 | 0.120 |
Why?
|
Antioxidants | 1 | 2023 | 1667 | 0.120 |
Why?
|
Mycobacterium tuberculosis | 2 | 2023 | 1912 | 0.120 |
Why?
|
Bone Marrow | 1 | 2005 | 2911 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2002 | 1651 | 0.120 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1936 | 0.120 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2021 | 799 | 0.120 |
Why?
|
STAT1 Transcription Factor | 2 | 2006 | 340 | 0.120 |
Why?
|
Exercise Test | 3 | 2021 | 2165 | 0.120 |
Why?
|
Dyspnea | 2 | 2021 | 1347 | 0.120 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2019 | 541 | 0.120 |
Why?
|
Immunotherapy | 2 | 2021 | 4642 | 0.120 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 731 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 1963 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1160 | 0.110 |
Why?
|
Mucus | 4 | 2016 | 342 | 0.110 |
Why?
|
Lymphocyte Activation | 7 | 2011 | 5478 | 0.110 |
Why?
|
Cell Movement | 6 | 2013 | 5195 | 0.110 |
Why?
|
Precancerous Conditions | 1 | 2021 | 982 | 0.110 |
Why?
|
Cell Proliferation | 6 | 2013 | 10422 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 918 | 0.110 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1022 | 0.110 |
Why?
|
Male | 31 | 2024 | 360693 | 0.110 |
Why?
|
Receptors, CCR5 | 2 | 2021 | 487 | 0.110 |
Why?
|
Receptors, CCR4 | 2 | 2013 | 77 | 0.110 |
Why?
|
Interferon-gamma | 5 | 2019 | 3155 | 0.110 |
Why?
|
Cell Dedifferentiation | 1 | 2013 | 122 | 0.100 |
Why?
|
Multiprotein Complexes | 1 | 2019 | 1112 | 0.100 |
Why?
|
Immunophenotyping | 3 | 2020 | 1867 | 0.100 |
Why?
|
Antiviral Agents | 2 | 2023 | 3048 | 0.100 |
Why?
|
Lymphocyte Subsets | 1 | 2013 | 312 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1448 | 0.100 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2019 | 830 | 0.100 |
Why?
|
Hyperplasia | 2 | 2021 | 1150 | 0.100 |
Why?
|
Pandemics | 3 | 2020 | 8663 | 0.100 |
Why?
|
Gene Knockout Techniques | 2 | 2013 | 801 | 0.100 |
Why?
|
Receptors, OX40 | 1 | 2011 | 46 | 0.100 |
Why?
|
Chemokine CCL11 | 1 | 2011 | 128 | 0.100 |
Why?
|
Positron-Emission Tomography | 3 | 2020 | 6585 | 0.100 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 2011 | 117 | 0.100 |
Why?
|
Pulmonary Embolism | 1 | 2005 | 2571 | 0.100 |
Why?
|
Mitogens | 1 | 2011 | 229 | 0.090 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2011 | 41 | 0.090 |
Why?
|
Microscopy | 1 | 2016 | 904 | 0.090 |
Why?
|
Cell Extracts | 1 | 2011 | 135 | 0.090 |
Why?
|
Neutrophil Infiltration | 2 | 2012 | 390 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2020 | 2881 | 0.090 |
Why?
|
Phosphoproteins | 1 | 2020 | 2444 | 0.090 |
Why?
|
Immunoglobulin E | 3 | 2006 | 1505 | 0.090 |
Why?
|
Female | 32 | 2024 | 392544 | 0.090 |
Why?
|
Interleukin-5 | 1 | 2011 | 266 | 0.090 |
Why?
|
Tuberculosis | 1 | 2023 | 2016 | 0.090 |
Why?
|
Fibrosis | 3 | 2023 | 2051 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2451 | 0.090 |
Why?
|
Lung Compliance | 2 | 2009 | 200 | 0.090 |
Why?
|
Cats | 1 | 2011 | 974 | 0.090 |
Why?
|
Cough | 2 | 2011 | 594 | 0.080 |
Why?
|
Molecular Probe Techniques | 1 | 2010 | 111 | 0.080 |
Why?
|
Airway Resistance | 2 | 2009 | 405 | 0.080 |
Why?
|
Chemokine CCL22 | 1 | 2009 | 27 | 0.080 |
Why?
|
Tomography, Optical | 1 | 2010 | 129 | 0.080 |
Why?
|
Phenotype | 3 | 2023 | 16575 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2189 | 0.080 |
Why?
|
Chemokine CCL17 | 1 | 2009 | 26 | 0.080 |
Why?
|
Integrases | 1 | 2011 | 518 | 0.080 |
Why?
|
Receptors, CCR8 | 1 | 2008 | 28 | 0.080 |
Why?
|
Cell Migration Inhibition | 2 | 2006 | 97 | 0.080 |
Why?
|
Chemokine CCL2 | 1 | 2011 | 602 | 0.080 |
Why?
|
Myofibroblasts | 2 | 2023 | 223 | 0.080 |
Why?
|
Neoplasms | 4 | 2024 | 22140 | 0.080 |
Why?
|
Adenosine Triphosphate | 1 | 2015 | 1988 | 0.080 |
Why?
|
Lung Injury | 1 | 2013 | 422 | 0.080 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2012 | 1351 | 0.080 |
Why?
|
Th17 Cells | 1 | 2015 | 794 | 0.080 |
Why?
|
Cell Polarity | 1 | 2011 | 638 | 0.080 |
Why?
|
Hypoventilation | 1 | 2008 | 44 | 0.080 |
Why?
|
Sequence Deletion | 1 | 2012 | 1487 | 0.070 |
Why?
|
Antibodies | 2 | 2016 | 2415 | 0.070 |
Why?
|
Cell Count | 1 | 2011 | 1831 | 0.070 |
Why?
|
Cell Differentiation | 4 | 2023 | 11509 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2016 | 5871 | 0.070 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2011 | 698 | 0.070 |
Why?
|
Monocytes | 2 | 2023 | 2570 | 0.070 |
Why?
|
Biological Transport | 1 | 2011 | 2080 | 0.070 |
Why?
|
Radiography | 2 | 2010 | 6974 | 0.070 |
Why?
|
Paralysis | 1 | 2008 | 250 | 0.070 |
Why?
|
Lymph Nodes | 3 | 2008 | 3461 | 0.070 |
Why?
|
Chemokine CXCL11 | 2 | 2006 | 43 | 0.070 |
Why?
|
Macrophages | 3 | 2023 | 5753 | 0.070 |
Why?
|
Transplantation Tolerance | 1 | 2011 | 620 | 0.070 |
Why?
|
Leukotriene B4 | 2 | 2005 | 280 | 0.060 |
Why?
|
Tidal Volume | 1 | 2008 | 488 | 0.060 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2007 | 822 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 2426 | 0.060 |
Why?
|
Models, Immunological | 1 | 2008 | 515 | 0.060 |
Why?
|
Natural Killer T-Cells | 1 | 2009 | 322 | 0.060 |
Why?
|
Adipocytes | 1 | 2012 | 1190 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2916 | 0.060 |
Why?
|
Heart Diseases | 1 | 1998 | 2795 | 0.060 |
Why?
|
Reference Standards | 2 | 2020 | 1005 | 0.060 |
Why?
|
Immunologic Memory | 1 | 2011 | 1361 | 0.060 |
Why?
|
Th1 Cells | 2 | 2008 | 1042 | 0.060 |
Why?
|
Epinephrine | 1 | 2008 | 791 | 0.060 |
Why?
|
Adult | 15 | 2023 | 221119 | 0.060 |
Why?
|
Exercise | 2 | 1998 | 5874 | 0.060 |
Why?
|
Middle Aged | 16 | 2024 | 220853 | 0.060 |
Why?
|
Lymphocyte Count | 1 | 2006 | 781 | 0.060 |
Why?
|
Homeostasis | 1 | 2015 | 3320 | 0.060 |
Why?
|
Infarction | 1 | 2005 | 248 | 0.060 |
Why?
|
Phosphorylation | 2 | 2012 | 8300 | 0.060 |
Why?
|
HLA-DR Antigens | 1 | 2005 | 606 | 0.060 |
Why?
|
Conscious Sedation | 1 | 2008 | 533 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2008 | 1695 | 0.060 |
Why?
|
Bone Marrow Diseases | 1 | 2005 | 233 | 0.050 |
Why?
|
Paroxetine | 1 | 2024 | 181 | 0.050 |
Why?
|
Transcription Factors | 1 | 2023 | 12099 | 0.050 |
Why?
|
Acute Disease | 2 | 2011 | 7226 | 0.050 |
Why?
|
Antigen-Presenting Cells | 1 | 2006 | 965 | 0.050 |
Why?
|
Serum Response Factor | 1 | 2023 | 78 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13385 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2635 | 0.050 |
Why?
|
Pain | 2 | 2010 | 5072 | 0.050 |
Why?
|
Influenza A virus | 2 | 2021 | 458 | 0.050 |
Why?
|
Nausea | 1 | 2005 | 678 | 0.050 |
Why?
|
Lymphocytes | 2 | 2008 | 2603 | 0.050 |
Why?
|
Disease Susceptibility | 1 | 2009 | 1791 | 0.050 |
Why?
|
Injections, Intraperitoneal | 1 | 2002 | 413 | 0.050 |
Why?
|
Protein Kinases | 1 | 2008 | 1607 | 0.050 |
Why?
|
Respiration | 1 | 2008 | 1656 | 0.050 |
Why?
|
Back Pain | 1 | 2005 | 545 | 0.050 |
Why?
|
Endothelium | 1 | 2024 | 763 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2023 | 585 | 0.050 |
Why?
|
Interleukin-6 | 2 | 2021 | 3210 | 0.050 |
Why?
|
Cell Culture Techniques | 2 | 2021 | 1662 | 0.050 |
Why?
|
Chemokine CCL5 | 1 | 2021 | 214 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12976 | 0.050 |
Why?
|
Bone Marrow Transplantation | 1 | 2009 | 2692 | 0.050 |
Why?
|
Stem Cells | 1 | 2013 | 3517 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2011 | 5250 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2005 | 1838 | 0.040 |
Why?
|
Administration, Inhalation | 2 | 2020 | 1159 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 4 | 2021 | 20588 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2012 | 3313 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2871 | 0.040 |
Why?
|
Leg | 1 | 2005 | 1087 | 0.040 |
Why?
|
Mice, Inbred C3H | 2 | 2012 | 914 | 0.040 |
Why?
|
Intubation, Intratracheal | 3 | 2020 | 1331 | 0.040 |
Why?
|
Antigens | 3 | 2013 | 1441 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2015 | 11856 | 0.040 |
Why?
|
RNA Interference | 1 | 2008 | 2816 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 651 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10088 | 0.040 |
Why?
|
Reperfusion Injury | 1 | 2006 | 1026 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 59221 | 0.040 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2000 | 201 | 0.040 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2000 | 213 | 0.040 |
Why?
|
Prone Position | 1 | 2020 | 196 | 0.040 |
Why?
|
Ligands | 1 | 2006 | 3264 | 0.040 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2005 | 614 | 0.040 |
Why?
|
Bronchial Provocation Tests | 1 | 2019 | 216 | 0.040 |
Why?
|
Coronavirus | 1 | 2021 | 156 | 0.040 |
Why?
|
Equipment Design | 2 | 2021 | 3510 | 0.040 |
Why?
|
Ventriculography, First-Pass | 1 | 1998 | 20 | 0.040 |
Why?
|
Base Sequence | 2 | 2010 | 12404 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2010 | 2056 | 0.040 |
Why?
|
Mucous Membrane | 1 | 2021 | 659 | 0.040 |
Why?
|
Physical Exertion | 1 | 2021 | 668 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2020 | 281 | 0.040 |
Why?
|
Neutrophils | 2 | 2013 | 3763 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2010 | 3089 | 0.040 |
Why?
|
Streptococcus pyogenes | 1 | 2000 | 292 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7571 | 0.040 |
Why?
|
Patient Positioning | 1 | 2020 | 326 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2013 | 4021 | 0.040 |
Why?
|
Nanotechnology | 1 | 2023 | 713 | 0.040 |
Why?
|
Collagen | 1 | 2005 | 2635 | 0.030 |
Why?
|
Birefringence | 1 | 2016 | 54 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 1999 | 691 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9319 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2020 | 655 | 0.030 |
Why?
|
Muscle Relaxation | 1 | 2016 | 138 | 0.030 |
Why?
|
Endothelium, Vascular | 2 | 2006 | 4420 | 0.030 |
Why?
|
Receptors, CCR6 | 2 | 2007 | 74 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2005 | 4537 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2020 | 578 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 1998 | 288 | 0.030 |
Why?
|
Haploinsufficiency | 1 | 2018 | 336 | 0.030 |
Why?
|
Cell Line | 3 | 2021 | 15545 | 0.030 |
Why?
|
Blood Glucose | 1 | 2010 | 6392 | 0.030 |
Why?
|
Insulin | 1 | 2010 | 6588 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2020 | 989 | 0.030 |
Why?
|
Harmine | 1 | 2015 | 11 | 0.030 |
Why?
|
Virus Replication | 1 | 2023 | 2426 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 931 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1999 | 1128 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2024 | 1165 | 0.030 |
Why?
|
Streptococcal Infections | 1 | 2000 | 617 | 0.030 |
Why?
|
Cardiac Output | 1 | 1998 | 831 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2013 | 6341 | 0.030 |
Why?
|
Aged | 7 | 2024 | 169288 | 0.030 |
Why?
|
Sus scrofa | 1 | 2016 | 428 | 0.030 |
Why?
|
Arteriosclerosis | 1 | 1999 | 1056 | 0.030 |
Why?
|
Liver | 1 | 2010 | 7514 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2020 | 808 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2023 | 2731 | 0.030 |
Why?
|
Simian immunodeficiency virus | 1 | 2019 | 810 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2021 | 22174 | 0.030 |
Why?
|
Quality Control | 1 | 2016 | 833 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 2021 | 1009 | 0.030 |
Why?
|
Hemodynamics | 2 | 2021 | 4165 | 0.030 |
Why?
|
Receptors, CCR7 | 1 | 2013 | 106 | 0.030 |
Why?
|
Gene Expression | 3 | 2013 | 7571 | 0.030 |
Why?
|
Leptin | 1 | 2021 | 1595 | 0.030 |
Why?
|
Cartilage | 1 | 2016 | 807 | 0.030 |
Why?
|
Interleukin-4 | 2 | 2007 | 1154 | 0.030 |
Why?
|
Leukocytes | 1 | 2020 | 2025 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3328 | 0.030 |
Why?
|
Interleukin-1alpha | 1 | 2012 | 86 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2019 | 2328 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 1998 | 1867 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2016 | 1200 | 0.020 |
Why?
|
Doxycycline | 1 | 2013 | 344 | 0.020 |
Why?
|
Dogs | 1 | 2016 | 3832 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2000 | 2136 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1356 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 1998 | 1780 | 0.020 |
Why?
|
Risk Factors | 2 | 2021 | 74239 | 0.020 |
Why?
|
Hamartoma | 1 | 2013 | 236 | 0.020 |
Why?
|
Mice, Inbred A | 1 | 2010 | 245 | 0.020 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2013 | 262 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2019 | 2307 | 0.020 |
Why?
|
Piperazines | 1 | 2000 | 2522 | 0.020 |
Why?
|
Mice, Obese | 1 | 2010 | 418 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4243 | 0.020 |
Why?
|
Rabbits | 2 | 2010 | 4750 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1838 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2545 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3821 | 0.020 |
Why?
|
Tamoxifen | 1 | 2013 | 965 | 0.020 |
Why?
|
Patient Selection | 1 | 2021 | 4246 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6781 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 1462 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 39957 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9652 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1602 | 0.020 |
Why?
|
Immunization | 1 | 2013 | 1218 | 0.020 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2013 | 517 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 502 | 0.020 |
Why?
|
Computer-Aided Design | 1 | 2010 | 297 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8519 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8837 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41496 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2013 | 1176 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2010 | 846 | 0.020 |
Why?
|
Critical Care | 1 | 2000 | 2696 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2021 | 3952 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5295 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2024 | 4822 | 0.020 |
Why?
|
Egg Proteins | 1 | 2006 | 57 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2010 | 597 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 80674 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2008 | 346 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2012 | 1002 | 0.020 |
Why?
|
Chemokine CXCL6 | 1 | 2006 | 14 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2013 | 1891 | 0.020 |
Why?
|
Spleen | 1 | 2012 | 2290 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2010 | 1822 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2010 | 5103 | 0.020 |
Why?
|
Sepsis | 1 | 2000 | 2585 | 0.020 |
Why?
|
Receptors, Interleukin-8A | 1 | 2005 | 47 | 0.020 |
Why?
|
Receptors, Scavenger | 1 | 2006 | 123 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 2814 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10516 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58952 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20119 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2013 | 1520 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2006 | 864 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2010 | 4167 | 0.020 |
Why?
|
Algorithms | 1 | 2005 | 14025 | 0.020 |
Why?
|
Receptors, CCR2 | 1 | 2005 | 214 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12676 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 15920 | 0.010 |
Why?
|
Cell Survival | 1 | 2013 | 5778 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 64681 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4052 | 0.010 |
Why?
|
Virulence Factors, Bordetella | 1 | 2002 | 154 | 0.010 |
Why?
|
Interleukin-17 | 1 | 2008 | 913 | 0.010 |
Why?
|
Pertussis Toxin | 1 | 2002 | 176 | 0.010 |
Why?
|
Autophagy | 1 | 2010 | 1327 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9477 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5842 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1998 | 15308 | 0.010 |
Why?
|
Nebulizers and Vaporizers | 1 | 2002 | 139 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10707 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2006 | 1251 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2010 | 12747 | 0.010 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2000 | 32 | 0.010 |
Why?
|
3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2000 | 56 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 2002 | 602 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6504 | 0.010 |
Why?
|
Hypertension | 1 | 2020 | 8536 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2006 | 3091 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 2005 | 1076 | 0.010 |
Why?
|
Aerosols | 1 | 2002 | 635 | 0.010 |
Why?
|
Positive-Pressure Respiration, Intrinsic | 1 | 1999 | 10 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13402 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2007 | 2194 | 0.010 |
Why?
|
Integrins | 1 | 2002 | 835 | 0.010 |
Why?
|
Prognosis | 1 | 1998 | 29687 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17598 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1999 | 1545 | 0.010 |
Why?
|
Sulfones | 1 | 2000 | 448 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 1998 | 379 | 0.010 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2000 | 451 | 0.010 |
Why?
|
Tunica Intima | 1 | 1999 | 458 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54435 | 0.010 |
Why?
|
Acidosis, Lactic | 1 | 1998 | 146 | 0.010 |
Why?
|
Pulmonary Ventilation | 1 | 1999 | 371 | 0.010 |
Why?
|
Purines | 1 | 2000 | 609 | 0.010 |
Why?
|
Receptors, LDL | 1 | 1999 | 489 | 0.010 |
Why?
|
Drug Synergism | 1 | 2000 | 1756 | 0.010 |
Why?
|
Child | 1 | 2023 | 80152 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14675 | 0.010 |
Why?
|
Survival Rate | 1 | 2008 | 12728 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 1999 | 1443 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 1999 | 1967 | 0.010 |
Why?
|
Esophagus | 1 | 1999 | 1036 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 1999 | 1141 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 1999 | 2199 | 0.010 |
Why?
|
Aorta | 1 | 1999 | 2040 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9416 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 16952 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 88298 | 0.000 |
Why?
|